Home/Filings/4/0001104659-18-016854
4//SEC Filing

GOLDENBERG DAVID M 4

Accession 0001104659-18-016854

CIK 0000722830other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 8:32 PM ET

Size

13.7 KB

Accession

0001104659-18-016854

Insider Transaction Report

Form 4
Period: 2018-02-28
GOLDENBERG DAVID M
DirectorCSO, CMO and Chairman10% Owner
Transactions
  • Sale

    Common Stock

    2018-03-07$17.50/sh20,000$350,0001,774,285 total
  • Sale

    Common Stock

    2018-03-07$17.60/sh20,000$352,0005,633,252 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-03-05$17.30/sh20,000$346,0005,673,252 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-03-05$17.17/sh20,000$343,4005,653,252 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-02-28$17.09/sh17,729$302,9895,693,252 total(indirect: See Footnote)
  • Sale

    Common Stock

    2018-03-07$17.75/sh20,000$355,0005,613,252 total(indirect: See Footnote)
Footnotes (3)
  • [F1]Such shares were held by the reporting person's spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan.
  • [F2]Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company.
  • [F3]Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.

Documents

1 file

Issuer

IMMUNOMEDICS INC

CIK 0000722830

Entity typeother

Related Parties

1
  • filerCIK 0001029578

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 8:32 PM ET
Size
13.7 KB